A STUDY OF THE EFFECTIVENESS OF THE IRON-CHELATING AGENT DEFEROXAMINE AS VASOSPASM PROPHYLAXIS IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE

被引:64
|
作者
VOLLMER, DG
HONGO, K
OGAWA, H
TSUKAHARA, T
KASSELL, NF
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT NEUROSURG,CHARLOTTESVILLE,VA 22903
[2] WASHINGTON UNIV,SCH MED,DEPT NEUROSURG,ST LOUIS,MO 63110
关键词
DEFEROXAMINE; FREE RADICAL; IRON; SUBARACHNOID HEMORRHAGE; VASOSPASM;
D O I
10.1227/00006123-199101000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pathogenesis of cerebral vasospasm occurring after subarachnoid hemorrhage (SAH) is unknown. Several lines of experimentation have suggested a free radical mechanism in the etiology of vasospasm. Iron is an important catalyst in the generation of free radicals and lipid peroxides in response to tissue injury. We hypothesize that the elaboration of iron from the subarachnoid clot might result in enhanced generation of free radicals and lipid peroxidation. If so, then treatment with deferoxamine, an iron-chelating compound, might reduce the formation of free radicals and thereby ameliorate vasospasm. This hypothesis was examined in a rabbit model of experimental cerebral vasospasm. New Zealand White rabbits were divided into the following experimental groups: control (normal) animals (n = 7), control animals treated with deferoxamine (n = 3), animals subjected to SAH and killed on Day 2 (n = 7), animals subjected to SAH on Day 2 and treated with deferoxamine (n = 9), animals subjected to SAH killed on Day 3 (n = 7), and animals subjected to SAH on Day 3 and treated with deferoxamine (n = 7). Deferoxamine treatment (50 mg/kg/ 8 hours) was begun 16 hours before the induction of SAH and continued until the animals were killed by perfusion fixation. The basilar artery caliber was assessed using morphometric techniques. The diameter of the basilar arteries in the control animals was 0.64 +/- 0.02 mm. Deferoxamine treatment alone did not alter the artery diameter. SAH resulted in a decrease in basilar artery diameter by 20% on Day 2 and 27% on Day 3. Deferoxamine treatment attenuated the SAH-induced spasm minimally on Day 2 but significantly on Day 3 (Day 3 diameter = 0.60 +/- 0.04; P < 0.015). These preliminary results show promise for deferoxamine therapy in the treatment of vasospasm occurring after SAH. These data support the notion that SAH-induced vasospasm is mediated iron, possibly via the generation of free radicals.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 41 条
  • [21] PROTECTIVE ACTION OF IRON-CHELATING AGENTS (CATECHOL, MIMOSINE, DEFEROXAMINE, AND KOJIC ACID) AGAINST ISCHEMIA-REPERFUSION INJURY OF ISOLATED NEONATAL RABBIT HEARTS
    KATOH, S
    TOYAMA, J
    KODAMA, I
    KAMIYA, K
    AKITA, T
    ABE, T
    EUROPEAN SURGICAL RESEARCH, 1992, 24 (06) : 349 - 355
  • [22] Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in ThailandA Cost-Effectiveness Study
    Nantasit Luangasanatip
    Nathorn Chaiyakunapruk
    Nilawan Upakdee
    Peerapon Wong
    Clinical Drug Investigation, 2011, 31 : 493 - 505
  • [23] Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in Thailand A Cost-Effectiveness Study
    Luangasanatip, Nantasit
    Chaiyakunapruk, Nathorn
    Upakdee, Nilawan
    Wong, Peerapon
    CLINICAL DRUG INVESTIGATION, 2011, 31 (07) : 493 - 505
  • [24] Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model
    Tsurutani, H
    Ohkuma, H
    Suzuki, S
    STROKE, 2003, 34 (06) : 1497 - 1500
  • [25] Human tissue kallikrein ameliorates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage (vol 37, pg 1082, 2016)
    Mo Yunchang
    Dai Qinxue
    Ji Binbin
    NEUROLOGICAL RESEARCH, 2016, 38 (08) : 751 - 751
  • [26] The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm subarachnoid in a rabbit model of hemorrhage
    Barbosa, MD
    Arthur, AS
    Louis, RH
    MacDonald, T
    Polin, RS
    Gazak, C
    Kassell, NF
    NEUROSURGERY, 2001, 49 (05) : 1205 - 1212
  • [27] Punica granatum L. Juice Attenuates Experimental Cerebral Vasospasm in the Rabbit Subarachnoid Hemorrhage Model: A Basilar Artery Morphometric Study and Apoptosis
    Guvenc, Yahya
    Demirci, Adnan
    Billur, Deniz
    Aydin, Sevim
    Ozeren, Ersin
    Bayram, Pinar
    Dilli, Alper
    Gokce, Emre Cemal
    Yaman, Onur
    Celik, Haydar
    Karatay, Mete
    Alagoz, Fatih
    Kaptanoglu, Erkan
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2017, 78 (02) : 124 - 131
  • [28] Intracranial delivery of ibuprofen from a controlled-release polymer prevents chronic vasospasm in a rabbit subarachnoid hemorrhage model
    Frazier, JL
    Pradilla, G
    Wang, PP
    Tamargo, RJ
    NEUROSURGERY, 2003, 53 (02) : 510 - 510
  • [29] Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage
    Frazier, JL
    Pradilla, G
    Wang, PP
    Tamargo, RJ
    JOURNAL OF NEUROSURGERY, 2004, 101 (01) : 93 - 98
  • [30] A new rabbit model for the study of early brain injury after subarachnoid hemorrhage
    Marbacher, Serge
    Andereggen, Lukas
    Neuschmelting, Volker
    Widmer, Hans Rudolf
    von Gunten, Michael
    Takala, Jukka
    Jakob, Stephan M.
    Fandino, Javier
    JOURNAL OF NEUROSCIENCE METHODS, 2012, 208 (02) : 138 - 145